43
Participants
Start Date
September 30, 2007
Primary Completion Date
August 31, 2011
Study Completion Date
August 31, 2011
Centella asiatica selected triterpenes (CAST)
Drug provided to subjects in 60 mg capsules. Dose escalation phase: subjects take 2 capsules/day for weeks 1-4, 3 capsules/day for weeks 4-8 and 4 capsules/day weeks 8-12. Subjects remain on highest tolerated dose from week 12 to 52.
Placebo
"Placebo provided to subjects in 60 mg color-matched capsules. Dose escalation phase: subjects take 2 capsules/day for weeks 1-4, 3 capsules/day for weeks 4-8 and 4 capsules/day weeks 8-12. Subjects remain on highest tolerated dose from week 12 to 52."
Oregon Health and Science University, Portland
National Center for Complementary and Integrative Health (NCCIH)
NIH
Oregon Health and Science University
OTHER